Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShare-based Compensation (IS)Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ascendis Pharma A (ASND) Tax Provisions: 2012-2024

Historic Tax Provisions for Ascendis Pharma A (ASND) over the last 13 years, with Dec 2024 value amounting to $5.2 million.

  • Ascendis Pharma A's Tax Provisions fell 277.48% to -$4.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$8.6 million, marking a year-over-year decrease of 77.05%. This contributed to the annual value of $5.2 million for FY2024, which is 33.29% down from last year.
  • Latest data reveals that Ascendis Pharma A reported Tax Provisions of $5.2 million as of FY2024, which was down 33.29% from $7.9 million recorded in FY2023.
  • In the past 5 years, Ascendis Pharma A's Tax Provisions registered a high of $7.9 million during FY2023, and its lowest value of -$419,837 during FY2021.
  • Over the past 3 years, Ascendis Pharma A's median Tax Provisions value was $5.5 million (recorded in 2022), while the average stood at $6.2 million.
  • Its Tax Provisions has fluctuated over the past 5 years, first plummeted by 106,758.32% in 2020, then spiked by 1,406.67% in 2022.
  • Over the past 5 years, Ascendis Pharma A's Tax Provisions (Yearly) stood at -$250,048 in 2020, then slumped by 67.90% to -$419,837 in 2021, then skyrocketed by 1,406.67% to $5.5 million in 2022, then skyrocketed by 43.23% to $7.9 million in 2023, then slumped by 33.29% to $5.2 million in 2024.